CCL2 and Alzheimer disease: As shown in Figure 6, TNFα primed-AD-MSCs-CM (P-AD-MSCs-CM) added to U937 enhanced inhibition of RANTES and MCP-1 release by U937, either in the presence or absence of TNFα stimuli.